GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, MMP2, MMP9, NQO1, PPARA, TRPV1, TYR |
8.31785 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.87413 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, NQO1, TYR |
7.74481 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, TBXAS1, TRPV1 |
7.12706 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.06784 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.74891 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, NQO1, PPARA, TRPV1, TYR |
6.74891 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.74891 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.02391 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, HSD11B2, NQO1, TRPV1, TYR |
6.02391 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MCL1, NQO1, PPARA, TNKS, TNKS2, TRPV1, XDH |
5.97011 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, MMP9, NQO1, PPARA, TRPV1, TYR |
5.86214 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, PIM1, PPARA, TBXAS1, TYR, XDH |
5.78897 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, NQO1, PPARA, TRPV1 |
5.72725 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO1, TBXAS1, TYR, XDH |
4.98773 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.84456 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.81682 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, MMP2, NQO1, PPARA, TRPV1 |
4.51675 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, MCL1, MMP2, MMP9, NQO1, PIM1, PPARA, TNKS2, TYR |
4.49617 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, NQO1, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.48732 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.24778 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.13993 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GPR35, MCL1, MMP1, MMP2, MMP9, NQO1, PIM1, PPARA, PTPN1, TNKS, TNKS2, TRPV1, XDH |
4.12445 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.98317 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
3.95335 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.70685 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.61279 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, NQO1 |
3.61279 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HSD11B2, NQO1, TRPV1 |
3.59295 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GPR35, MCL1, MMP1, MMP2, MMP9, NQO1, PIM1, PPARA, PTPN1, TNKS, TNKS2, TRPV1, XDH |
3.45904 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4, NQO1 |
3.45904 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALPL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, MCL1, MMP1, MMP2, MMP9, PIM1, PPARA, TNKS2, TRPV1, TYR |
3.41931 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, MCL1, MMP9, PIM1, PPARA, TYR |
3.39476 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.3388 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2 |
3.19848 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.16229 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.09099 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PPARA, TYR |
3.04378 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, MMP9, NQO1 |
2.85934 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.85659 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, MMP1, MMP2, NQO1, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.77158 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.75646 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.66281 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA |
2.62403 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.60908 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, NQO1 |
2.60756 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, PPARA, TBXAS1 |
2.58998 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.53228 |
[BP] GO:0044092 |
negative regulation of molecular function
|
CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, GPR35, MMP9, NQO1, PIM1, PPARA, PTPN1, TNKS |
2.4925 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, NQO1 |
2.4678 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HSD11B2, NQO1, TRPV1, TYR |
2.44972 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, NQO1, TRPV1, TYR |
2.43222 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.43222 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.41236 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.40627 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.36956 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MMP1, MMP2, MMP9, XDH |
2.30434 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, BCL2, CNR1, CYP1A1, HSD11B2, NQO1, TRPV1, TYR |
2.29035 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.29035 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.29035 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, MMP2, MMP9, PIM1, XDH |
2.29006 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, NQO1, PIM1, PPARA, PTPN1, TRPV1, XDH |
2.28083 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, ESR1, F3, MMP2, MMP9, PIM1 |
2.28083 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, GPR35, MCL1, MMP9, PTPN1, TNKS, TNKS2, XDH |
2.26609 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.26055 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, NQO1 |
2.26055 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, GPR35, MCL1, MMP9, PTPN1, TNKS, TNKS2, XDH |
2.2575 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.22294 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.16583 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.16583 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.16583 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, MCL1, MMP9, NQO1, TRPV1, XDH |
2.12608 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, MMP9, NQO1, PPARA, PTPN1, TRPV1, TYR |
2.12176 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, NQO1, PIM1, PTPN1, TRPV1, XDH |
2.11028 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, MCL1, MMP9, NQO1, TRPV1, XDH |
2.10881 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CDK6, CNR1, TNKS, TNKS2, TRPV1 |
2.0925 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, GPR35, TRPV1 |
2.0925 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, NQO1, PIM1, PTPN1, TRPV1, XDH |
2.0925 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.0925 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.0925 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.0925 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.0925 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, MCL1, MMP2, MMP9, PIM1, PPARA, PTPN1, TNKS, TNKS2, TRPV1 |
2.06743 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, NQO1 |
2.02331 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, AOX1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MCL1, MMP2, MMP9, NQO1, PIM1, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
1.85042 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HSD11B1, HSD11B2, HSD17B2, TBXAS1 |
1.61722 |
[CC] GO:0016020 |
membrane
|
ACHE, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, MCL1, MMP2, PIM1, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR |
1.56596 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1, TBXAS1 |
1.17816 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, TRPV1 |
1.00183 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
12.8757 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.2724 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.5502 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, TNKS |
6.28054 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO1, TBXAS1, TYR, XDH |
6.02391 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, NQO1, PIM1, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
5.92158 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.81532 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.4818 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.51675 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.13993 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.13993 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.10334 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
3.95335 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.91573 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.91573 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.91339 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
3.86605 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.67178 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.58471 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.52227 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.50249 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.45904 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.4535 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.361 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, TRPV1 |
3.18471 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
2.85934 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, TBXAS1, XDH |
2.72898 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.70638 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.67299 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.66281 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.66281 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.503 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.41236 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.29035 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.25111 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.12176 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.0925 |